Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Eschbach

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 22, 2018
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CTWolfgang G Kunz, Ralf S Eschbach, Robert Stahl, et al.
Investigative Radiology|April 16, 2016
αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer XenograftsPhilipp Maximilian Kazmierczak, Moritz Schneider, Thomas Habereder, et al.
Plos One|October 4, 2018
Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanomaPhilipp M Kazmierczak, Neal C Burton, Georg Keinrath, et al.
Plos One|December 20, 2016
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast CancerPhilipp M Kazmierczak, Andrei Todica, Franz-Josef Gildehaus, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Plos One|February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validationRalf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Nature|November 22, 2019
A very-high-energy component deep in the γ-ray burst afterglowH Abdalla, R Adam, F Aharonian, et al.
Physical Review Letters|September 24, 2016
Search for Dark Matter Annihilations towards the Inner Galactic Halo from 10 Years of Observations with H.E.S.SH Abdallah, A Abramowski, F Aharonian, et al.
Physical Review Letters|June 5, 2018
Search for γ-Ray Line Signals from Dark Matter Annihilations in the Inner Galactic Halo from 10 Years of Observations with H.E.S.SH Abdallah, A Abramowski, F Aharonian, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 22, 2018
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CTWolfgang G Kunz, Ralf S Eschbach, Robert Stahl, et al.
Investigative Radiology|April 16, 2016
αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer XenograftsPhilipp Maximilian Kazmierczak, Moritz Schneider, Thomas Habereder, et al.
Plos One|October 4, 2018
Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanomaPhilipp M Kazmierczak, Neal C Burton, Georg Keinrath, et al.
Plos One|December 20, 2016
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast CancerPhilipp M Kazmierczak, Andrei Todica, Franz-Josef Gildehaus, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Plos One|February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validationRalf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Nature|November 22, 2019
A very-high-energy component deep in the γ-ray burst afterglowH Abdalla, R Adam, F Aharonian, et al.
Physical Review Letters|September 24, 2016
Search for Dark Matter Annihilations towards the Inner Galactic Halo from 10 Years of Observations with H.E.S.SH Abdallah, A Abramowski, F Aharonian, et al.
Physical Review Letters|June 5, 2018
Search for γ-Ray Line Signals from Dark Matter Annihilations in the Inner Galactic Halo from 10 Years of Observations with H.E.S.SH Abdallah, A Abramowski, F Aharonian, et al.
Pageof 3